Back to Journals » OncoTargets and Therapy » Volume 9


Authors Gu J, Sun R, Shen S, Yu Z

Received 20 November 2015

Accepted for publication 20 November 2015

Published 4 February 2016 Volume 2016:9 Pages 615—616


Gu J, Sun R, Shen S, Yu Z. The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer. Onco Targets Ther. 2015;8:2215–2225.

The first author (Junsheng Gu) created an email address for Dr Yu without permission and used figures from a previously published paper: Lin A, Wang G, Zhao H, et al. TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells. OncoImmunology. 2015: DOI:10.1080/2162402X.

This was done without the knowledge, involvement, or permission of Dr Yu.
This retraction relates to this paper

Creative Commons License © 2016 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.